Czerniecki BJ - Search Results

1

Reengineering dendritic cell-based anti-cancer vaccines.

Koski GK, Cohen PA, Roses RE, Xu S, Czerniecki BJ. Koski GK, et al. Among authors: czerniecki bj. Immunol Rev. 2008 Apr;222:256-76. doi: 10.1111/j.1600-065X.2008.00617.x. Immunol Rev. 2008. PMID: 18364007 Review.

2

Mature CD83(+) dendritic cells infected with recombinant gp100 vaccinia virus stimulate potent antimelanoma T cells.

Prabakaran I, Menon C, Xu S, Gómez-Yafal A, Czerniecki BJ, Fraker DL. Prabakaran I, et al. Among authors: czerniecki bj. Ann Surg Oncol. 2002 May;9(4):411-8. doi: 10.1007/BF02573878. Ann Surg Oncol. 2002. PMID: 11986195

3

Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism.

Xu S, Koski GK, Faries M, Bedrosian I, Mick R, Maeurer M, Cheever MA, Cohen PA, Czerniecki BJ. Xu S, et al. Among authors: czerniecki bj. J Immunol. 2003 Sep 1;171(5):2251-61. doi: 10.4049/jimmunol.171.5.2251. J Immunol. 2003. PMID: 12928369 Free article.

4

Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients.

Bedrosian I, Mick R, Xu S, Nisenbaum H, Faries M, Zhang P, Cohen PA, Koski G, Czerniecki BJ. Bedrosian I, et al. Among authors: czerniecki bj. J Clin Oncol. 2003 Oct 15;21(20):3826-35. doi: 10.1200/JCO.2003.04.042. J Clin Oncol. 2003. PMID: 14551301 Clinical Trial.

5

Combining innate immunity with radiation therapy for cancer treatment.

Koski GK, Czerniecki BJ. Koski GK, et al. Among authors: czerniecki bj. Clin Cancer Res. 2005 Jan 1;11(1):7-11. Clin Cancer Res. 2005. PMID: 15671522 Review. No abstract available.

6

Dendritic cells in melanoma immunotherapy.

Faries MB, Czerniecki BJ. Faries MB, et al. Among authors: czerniecki bj. Curr Treat Options Oncol. 2005 May;6(3):175-84. doi: 10.1007/s11864-005-0001-6. Curr Treat Options Oncol. 2005. PMID: 15869729 Review.

7

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.

Czerniecki BJ, Koski GK, Koldovsky U, Xu S, Cohen PA, Mick R, Nisenbaum H, Pasha T, Xu M, Fox KR, Weinstein S, Orel SG, Vonderheide R, Coukos G, DeMichele A, Araujo L, Spitz FR, Rosen M, Levine BL, June C, Zhang PJ. Czerniecki BJ, et al. Cancer Res. 2007 Feb 15;67(4):1842-52. doi: 10.1158/0008-5472.CAN-06-4038. Epub 2007 Feb 9. Cancer Res. 2007. PMID: 17293384 Clinical Trial.

8

Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.

Swoboda RK, Somasundaram R, Caputo L, Ochoa EM, Gimotty PA, Marincola FM, Van Belle P, Barth S, Elder D, Guerry D, Czerniecki B, Schuchter L, Vonderheide RH, Herlyn D. Swoboda RK, et al. Cancer Res. 2007 Apr 15;67(8):3555-9. doi: 10.1158/0008-5472.CAN-06-2763. Cancer Res. 2007. PMID: 17440064

9

Development of vaccines for high-risk ductal carcinoma in situ of the breast.

Czerniecki BJ, Roses RE, Koski GK. Czerniecki BJ, et al. Cancer Res. 2007 Jul 15;67(14):6531-4. doi: 10.1158/0008-5472.CAN-07-0878. Cancer Res. 2007. PMID: 17638860 Review.

10

STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells.

Cohen PA, Koski GK, Czerniecki BJ, Bunting KD, Fu XY, Wang Z, Zhang WJ, Carter CS, Awad M, Distel CA, Nagem H, Paustian CC, Johnson TD, Tisdale JF, Shu S. Cohen PA, et al. Among authors: czerniecki bj. Blood. 2008 Sep 1;112(5):1832-43. doi: 10.1182/blood-2007-12-130138. Epub 2008 Jun 24. Blood. 2008. PMID: 18577706 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results